Intervet/Schering-Plough Animal Health has announced that it is to sponsor the Equine Business Management Strategies (EBMS) program, a targeted business education program developed for equine veterinary surgeons and practice professionals.
According the company, this 5-day course has proven very successful in the United States. It had its European kick-off in Amsterdam on August 22, 2010, where a group of almost forty equine practitioners from North America and Europe gathered to discuss and learn how to apply business principles in their day-to-day work. The program was chaired by Dr. Joop Loomans, an equine veterinary surgeon responsible for equine business management education at the Department of Equine Sciences of the Veterinary Faculty of Utrecht University (The Netherlands).
Course participants worked with international specialists on strategic planning, benchmarking, branding and change management to create strategic plans to implement at their practices, and to share their knowledge, experience and ideas.
Intervet/Schering Plough says the launch of Equine Business Management Strategies program exceeded expectations of participants, sponsor and organizers. The chance to look at the day-to-day practice from a different angle and to learn about things like benchmarking exercises, revenue analysis and branding was highly appreciated. Participant Jeremy Mantell from Liphook Equine Hospital in the UK said: "The EBMS has given me a clearer understanding of what I need to change and develop in my practice."
Dr. Roberto Ragni-Alunni, Global Technical Manager Equine at Intervet/Schering-Plough Animal Health said: "We believe that running an equine practice is not based solely on technical and scientific skills but also on effective practice management. That is why our company has decided to support this initiative. Intervet/Schering-Plough Animal Health also continues its custom of providing not only innovating products, but also new, value-added services to strengthen its bond with veterinarians."
Seven veterinary surgeons who took their final assessments at the University of Liverpool on 6 September have become the first to receive the postgraduate RCVS Certificate in Advanced Veterinary Practice with equine designations.
Dr Mark Holmes, a member of the RCVS sub-committee for the CertAVP who observed the assessments at Liverpool said: "I was very impressed by the quality of all the candidates and the diligence of the examination process.
"It is clear that candidates putting themselves forward for 'named' certificates have demonstrated particular interest in their chosen fields and place considerable value on passing their synoptic examination."
The modular certificates were introduced in 2007 to be a more flexible replacement for the old-style postgraduate certificates. Vets can now choose from 79 subject modules, with RCVS-accredited assessments offered by a range of universities. These institutions may also offer associated courses which vets can take to support their studies, although candidates are free to choose where and how they wish to study.
To build their credits into the full CertAVP qualification candidates must first enrol with the RCVS, which keeps a record of modules achieved. Candidates need to take two compulsory modules, and several of a range of optional modules, within ten years in order to receive the award. Candidates aiming for a designated award must choose specific modules from amongst the options, and additionally pass an overarching 'synoptic' assessment.
For more information about the individual modules and the qualification as a whole, prospective candidates can visit www.rcvs.org.uk/modcerts.
A project which aims to standardise the assessment of veterinary nurse practical training across Europe will have life beyond its pilot phase, thanks to European VN training network, Vetnnet.
The announcement was made in September at an Oslo-based conference to mark the conclusion of the pilot phase of the Pan-European Practical Assessment System project (PEPAS).
During its two-year pilot, the Leonardo da Vinci-funded project developed 111 new stations for Objective Structured Clinical Examinations (OSCEs), including mark-sheets and examiner notes, and trained over 50 veterinary nursing examiners from eight countries across Europe. The new OSCE stations have been trialled across 250 students by seven European veterinary nurse schools.
Vetnnet has now committed to continuing the project, enabling its members to access the OSCEs and associated training.
The Royal College of Veterinary Surgeons was a main project partner in the pilot, with specific responsibility for training and quality assurance of the system. Victoria Hedges, RCVS VN Examination and Higher Education Quality Manager said: "It's great that the hard work put into the project by so many countries will continue to bear fruit.
"Feedback in Oslo was excellent and it was heartening to see that when examiners' marks were compared across countries, standardisation was very good. The feedback also helped us to see where students were not achieving the desire results, indicating where more training is needed."
See www.vetnnet.com for more information.
The University of Bristol's School of Biological Sciences has published* the results of a study which concludes that young dogs and those that are not wormed regularly are significantly more likely to be infected with the life-threatening, parasitic lungworm, Angiostrongylus vasorum.
In the independent study, which was led by Dr. Eric Morgan, the faeces of 900 dogs was tested to look for factors which may increase a dog's risk of infection and to identify signs of infection. Lungworm was found to be a common cause of disease in Southwest England and Wales - 16 per cent of dogs presenting symptoms tested positive for lungworm, as well as 2 per cent of seemingly healthy dogs. However, this is likely to be an underestimate. Dr Morgan said: "We used the Baermann's test to identify infected dogs, which is thought to be only 50% accurate, so the true figures may be as much as double those reported."
Dogs under 18 months were found to be 8 times more likely to have lungworm than dogs over 8 years old, and dogs between 18 months and 8 years old were 4 times more likely to have lungworm than dogs over 8 years old. Dogs tested positive for lungworm year-round but there was an increase in numbers diagnosed during the winter and spring.
According to Dr. Morgan, infected dogs may display a wide range of symptoms: while over half of infected dogs were reported to be coughing or having difficulty breathing, lungworm infection is not always associated with respiratory signs. Infected dogs may present any combination of a wide range of symptoms including lethargy, tiring easily with exercise, and gastrointestinal signs such as vomiting and diarrhoea. A significant number of infected dogs displayed signs of bleeding disorders such as excessive bleeding from small wounds or following surgery, blood in the urine and vomit, pale skin and bleeding in the eyes and skin.
Dr. Morgan added: "This parasite is spreading, reaching many new areas (including Bristol and Scotland) in the last few years. Disease can present in a variety of ways, not necessarily involving respiratory signs, so pet owners and their vets should be aware of the risk. Disease is most common in younger dogs, though age is not a barrier to infection. On the bright side, dogs that are treated regularly with appropriate wormers are at lower risk, so we can act to protect our pets' health."
*Morgan, E. R., Jefferies, R., van Otterdijk, L., McEniry, R. B., Allen, F., Bakewell, M. and Shaw, S. E. 2010. Angiostrongylus vasorum infection in dogs: Presentation and risk factors. Veterinary Parasitology. doi:10.1016/j.vetpar.2010.06.037
Dechra Veterinary Products has announced that Intubeaze Oromucosal Spray is now back in stock.
Intubeaze is used for local anaesthesia of the laryngeal mucosa of cats to facilitate endotracheal intubation by preventing the stimulation of the laryngeal reflex.
The product had gone out of stock due to a temporary manufacturing problem which has now been fixed.
Intubeaze is a clear solution containing 2% w/v lidocaine hydrochloride, with 0.1% w/v chlorocresol as an antimicrobial preservative. Intubeaze is now available through all wholesalers.
For further information on Intubeaze please contact Dechra on 01743 441 632 or visit www.dechra.co.uk.
The Disciplinary Committee of the RCVS has refused an application for restoration to the RCVS Register by Dr Janos Nemeth, who had previously been found to have fraudulently registered with the RCVS and struck off.
At the original hearing, in February 2009, Dr Nemeth - the holder of a veterinary science degree from the Szent István University in Budapest, who had practised in the Wokingham area of Berkshire - was found to have dishonestly entered his name in the RCVS Register using a forged document (a Certificate of Membership and Good Professional Behaviour from the Hungarian Veterinary Chamber). The Disciplinary Committee at that time found the evidence that the document was a forgery to be "overwhelming" and concluded that Dr Nemeth had been lying to them about his knowledge of the forgery. It directed that his name should be removed from the Register.
Dr Nemeth lodged an appeal against this decision with the Privy Council, but then took no further steps. Accordingly, the Privy Council dismissed Dr Nemeth's appeal and he was struck off in October 2009.
On lodging his application for restoration, Dr Nemeth had asserted he was not guilty of the original charge. The Committee was disappointed with this aspect of Dr Nemeth's application saying that he would be "well-advised to demonstrate some insight into the seriousness of the original findings."
The Committee emphasised that a finding of dishonesty against a member of the College is "one of great seriousness and never made lightly" and accepted that it may be considered "fundamentally incompatible with being a veterinary surgeon."
Questioning Dr Nemeth, the Committee was further disappointed to learn that he had not made himself more familiar with the RCVS Guide to Professional Conduct, or made a greater effort to keep up to date with veterinary practice in the UK, or provided documentary evidence of attendance at continuing professional development (CPD) meetings.
After considering all the facts presented to it, including the severe personal and financial impact on Dr Nemeth of his removal from the Register, the Committee was not satisfied that he was fit to be restored and did not consider it in the public interest to grant his application.
Acknowledging she could not bind a future Committee as to any further application for restoration by Dr Nemeth, Committee Chairman Mrs Caroline Freedman advised: "Dr Nemeth should provide supporting evidence where possible, including records of CPD, testimonials from other veterinary surgeons or employers, or a more incisive knowledge of the Guide to Professional Conduct. We would remind Dr Nemeth that the onus is on him to establish his fitness to be restored to the Register."
Merial has launched Equioxx, a new pain management product which the company says is the first COX-2 specific NSAID for horses
Traditional NSAIDs act by blocking the action of both COX-1 and COX-2 enzymes at the same time. Although COX-2 produces prostaglandins associated with both inflammation and pain, COX-1 has a pivotal role in maintaining normal physiological function, so inhibiting this enzyme may have an increased risk of side effects e.g. gastric ulceration. Merial says Equioxx is the only NSAID that is highly COX-2 selective (up to 643 times more selective for COX-2 than COX-1), acting to reduce pain and inflammation but without affecting the COX-1 enzyme at therapeutic levels.
Equioxx contains the active ingredient firocoxib, and Merial says it is proven to be effective at reducing chronic lameness in horses. Appearing in blood plasma within 30 minutes of oral dosing, its pharmacokinetic profile allows once daily dosing. Field studies have confirmed that firocoxib is highly effective at controlling pain and improving function in horses with chronic osteoarthritis.
Equioxx is available as either a low dose injectable solution or a palatable oral paste.
For more information contact Merial Customer Services on 0870 6000 123
Online veterinary pharmacy Vet-Medic has announced the results of a survey which showed that veterinary practices are charging pet owners 100% more than online pharmacies for well-known drugs.
The survey compared the prices charged by veterinary practices, online pharmacies, pet superstores, supermarkets and veterinary medicine suppliers. Amongst other things, it found a six-pack of Frontline for cats available online for £16.33, vs £38.95 in practice. Optimmune was available for £23.86, compared to a practice in North London selling it for £59.81.
Andrew Evans, Managing Director of Vet-Medic said: "This research offers huge insight into the pricing structures of pet medication. When we commissioned the research to help us keep our own pricing competitive, we made an assumption that online shopping should come out cheaper but were staggered by how much."
He added: "Not many pet owners are aware that vets are obliged, in most circumstances, to provide them with a prescription when asked. How and where the prescription medicine is purchased is actually the owners' choice."
The BVA responded to the survey yesterday. President-Elect Harvey Locke said: "The Vet-Medic claim that veterinary practices are over-inflating the price of veterinary medicines is an unfair accusation.
"Veterinary practices will mark up the cost of the medicines they supply in order to cover the costs of keeping and dispensing them. This includes having trained staff available, buying the necessary equipment, and storage facilities that are governed by strict rules, and covering the cost of wasted medicines that have a short shelf life.
"Online pharmacies have similar overheads but are able to buy in much larger quantities than the average veterinary practice due to the much higher volumes sold. Many of the internet prices revealed in the survey are around the same cost as veterinary practices can buy the medicines from wholesalers suggesting that some of the internet companies are sourcing cheaper drugs abroad.
"As with many products buying online can be cheaper and consumers have a choice. Many pet owners choose to use the veterinary practice pharmacy because a lot of advice and assistance is available, including demonstrations on how to administer the treatments.
"Vet-Medic's assertion that pet owners don't know that they can obtain a prescription from their veterinary surgeon is also false. Over 50% of UK practices are registered under the RCVS Practice Standards Scheme. One of the conditions of the scheme is that a notice must be displayed in the waiting room informing clients that prescriptions are available on request, the price of a prescription, and the price list of the top ten medicines that the practice has dispensed in the last three month period.
"It's important to remember that under the law veterinary practices are not allowed to fix the price of medicines. As they are independent businesses this means that it is up to each practice to charge according to their own circumstances to cover their individual overheads."
Bayer Animal Health has obtained two new licensed indications for its antiparasiticide, Advocate.
The first is that the product is now licensed for the treatment of Crenosoma vulpis using a single dose. The second is that in addition to the existing treatment of Angiostrongylus vasorum claim, Advocate is now indicated for its prevention, using monthly spot-on applications.
This comes at a time when, according to Bayer, independent market research shows that vets are diagnosing Angiostrongylus vasorum at an increasing rate. Figures for 2010 place the incidence of vets who have confirmed cases at 37%, more than double the 16% confirmed in 2008, with a further 19% of vets reporting suspected cases.
Bayer is also stepping up its 'Be Lungworm Aware' consumer campaign, with the addition of a local and national radio campaign throughout October. The public information style advert will warn owners of the dangers associated with the parasite A.vasorum, and urging them to stay vigilant for signs their dog may be infected.
Veterinary staff can also direct clients who wish to learn more about lungworm to http://www.lungworm.co.uk/.
For more information on Advocate, please contact your sales representative or telephone Bayer on 01635 563000.
Following last weekend's Mail on Sunday revelation that a number of well-known organisations have been routinely serving meat from animals which have not been humanely slaughtered, the BVA has written to the companies involved, both to express concerns about animal welfare and to renew calls for clearer labelling.
The Mail on Sunday found that meat slaughtered under certain religious rules without pre-stunning (including kosher and some halal meat), is entering the mainstream food chain without being labelled as such. The investigation found that the meat is being used in schools, hospitals, pub chains and sporting venues.
The investigation follows news reports that GateGourmet, one of the largest airline caterers, is considering making the majority of its meals halal.
The BVA is concerned that consumers are confused by existing food labels and supports moves by the European Parliament to introduce mandatory labelling of meat from non-stunned animals, including use of the meat in other products. The BVA also supports the concept of one clear EU-wide label that would indicate higher welfare throughout the food chain.
Professor Bill Reilly, President of the British Veterinary Association, said: "Whilst we understand the need to respect religious freedoms the BVA believes that all animals should be stunned before slaughter to ensure the highest possible welfare for the animals.
"The exemption for religious slaughter should therefore be kept to a minimum. Meat from animals slaughtered according to these religious rules should not used in the mainstream market, particularly if it is not labelled as such.
"Earlier this year the European Parliament voted in favour of the compulsory labelling of meat from non-stunned animals and the British Veterinary Association strongly welcomed this move.
"We believe that consumers do want to make choices based on higher animal welfare and not cause unnecessary suffering. They should have the right information to make those pro-welfare choices."
Pet owners visiting the University of Edinburgh's vet school will be able to relax in peaceful outdoor surroundings, thanks to a project supported by the BBC's Beechgrove Garden.
The primetime gardening show's team, together with volunteers and friends of the Royal (Dick) School of Veterinary Studies, have transformed a two-and-a-half-acre plot in the vet school grounds into a community garden.
The sloping landscaped garden features a network of paths surrounding flower beds, trees and bushes. Sculpted stone seats give visitors a place to relax. Clients of the Dick Vet are being invited to support the school by sponsoring a brick along a path that winds through the garden, or by sponsoring trees, plants or benches.
Lesley Watson, a Beechgrove Garden presenter, said: "We have had a lot of help from the community in creating this garden, in what was a huge site. The first part of the garden, next to the School buildings, is quite formal, but as it extends towards the hills beyond, it becomes a more relaxed space and starts to take on aspects of the wider landscape."
Professor Elaine Watson, Head of the Royal (Dick) School of Veterinary Studies, said: "This wonderful garden is a fantastic place for our pet owners to visit and also a beautiful green retreat for our staff and students to enjoy."
Inez Priestly, a dog owner whose pets have been treated at the Dick Vet, laid the first brick in the garden's path of memories, in honour of her late Cavalier King Spaniel, Treacle. Mrs Priestly said: "The treatment my dogs have received at the Dick Vet has been beyond words - the vets always empathise with their clients and go the extra mile to help. I'm delighted to lay this first brick in the new garden and hope this will encourage others to do the same, as a way of thanking the Dick Vet."
(Photos courtesy Norrie Russell, University of Edinburgh)
Dechra Veterinary Products has introduced two additional new products to its Veterinary Essentials range: Alvegesic vet and Clavudale.
Alvegesic vet contains butorphanol, a well-known and widely used drug for sedation, anaesthesia and analgesia in both dogs and cats. In horses, Alvegesic vet is indicated for analgesia and sedation.
Alvegesic vet is available in 10ml multidose vials and is licensed for administration by intravenous, intramuscular or subcutaneous routes, depending on indication, in both cats and dogs.
The other new addition to the Veterinary Essentials range is Clavudale, which contains the broad spectrum antibiotic amoxicillin, potentiated with clavulanic acid. Clavudale is bactericidal, active against a wide variety of bacterial organisms, including gram-positives and gram-negatives.
Clavudale is effective in treating a wide range of bacterial diseases of cats and dogs. These include: skin disease; soft tissue infections; dental infections; urinary tract infections; respiratory disease and enteritis. Clavudale is supplied in boxes of 24 tablets, with 4 blister strips of six tablets.
Further information on Alvegesic vet and Clavudale is available by calling Liz Rawlings at Dechra on 01743 441 632 or visiting www.dechra.com
Medivet has announced the appointment of John Bower MBE BVSc MRCVS to its Panel of Enquiry set up following coverage of the company on Panorama.
Mr Bower has been President of the British Veterinary Association, the British Small Animal Veterinary Association, and the Veterinary Practice Management Association.
Mr Bower said: "Medivet is a large partnership with numerous branches and I am looking forward to helping the partners assess and review the management of their practice to eliminate the sort of incidents and situations that were alleged in the Panorama programme. This panel will look deeply into the management and I have been convinced by the partners that they are determined to take appropriate measures where necessary."
Adi Nell, Medivet central partner and fellow member of the panel said: "We are delighted that John Bower is to be a part of our panel. John is not only an eminent vet of unquestionable ethical standing, but he set up and ran a medium-sized veterinary partnership for 38 years. His expertise will be crucial to Medivet, as the panel carries out its investigations and makes its recommendations over the next few months."
Mr Bower, who retired from general practice in 2007, is currently Veterinary Advisor to Petplan Insurance Company and a trustee of two national charities - Hearing Dogs for Deaf People and The Petplan Charitable Trust. Mr Bower was awarded the BSAVA Melton Award for meritorious contributions to Small Animal Practice in 1991, the MBE in 2010 for services to the BVA:AWF, and has authored or co-authored a number of books including Veterinary Practice Management, The Dog Owner's Veterinary Handbook and The Cat Owner's Veterinary Handbook.
Novartis Animal Health UK has announced that it is committed to maintaining a reliable supply of Bovidec BVD virus vaccine throughout the coming season.
The announcement comes following concerns surrounding the availability of BVD vaccines. Novartis Brand Manager Eugene Smyth said: "We have been in discussion with the regulatory authorities to try and ensure we can meet the demand over the coming months and we have a large team of territory managers and technical services veterinarians dedicated to supporting our customers through the season".
Bovidec BVD virus vaccine, immunises adult cattle against the BVD Type 1 virus and for active immunisation of calves against BVD Type II virus.
The Kennel Club Genetics Centre at the Animal Health Trust has identified a genetic mutation which causes progressive retinal atrophy (PRA) in Golden Retrievers, and developed a DNA test to identify carriers.
PRA is a retinal disease which causes loss of vision and leads to blindness. PRA cannot be treated - the most successful way to combat the inherited condition is to identify dogs that carry the mutation and develop informed breeding strategies.
The new DNA test has been developed following the identification of the mutation which causes the most common form of PRA among Golden Retrievers in Europe - known as GR_PRA1. The mutation which causes a second form of PRA is still to be identified.
Cathryn Mellersh, Head of Canine Genetics at the AHT, said: "Our research shows that this mutation is present in the UK Golden Retriever population, so it's likely that several hundred new carriers are being born each year and that Golden Retrievers are invariably going blind as a result.
"This new DNA test will enable breeders to learn whether their dogs are carriers of the mutation. This, in turn, will enable them to make better informed breeding decisions and therefore produce puppies which will not go blind as a result of this mutation."
Mike Townsend, Chairman of the Kennel Club Charitable Trust, said: "This is a real breakthrough and one which we hope will help to prevent blindness in many Golden Retrievers in the years to come. Every dog deserves to lead a healthy, happy life and it is important that we do all we can to ensure that future generations are given this opportunity. Our knowledge about inherited diseases in dogs is growing every day and the development of DNA tests such as this one allows breeders to ensure that the healthiest genes are passed down through the generations."
The DNA test for PRA follows the success of the AHT's DNA test launched last year to identify carriers of a mutation that causes primary lens luxation. This test identifies carriers in more than 12 breeds of dog, including Miniature Bull Terriers, Jack Russell Terriers, Parson Russell Terriers and Patterdale Terriers. To date more than 6,500 samples from 36 countries have been tested.
The Kennel Club Charitable Trust has committed £1.2 million to the Kennel Club Genetics Centre at the AHT, which will undertake research into approximately 25 inherited diseases over the next five years, facilitating the creation of further diagnostic tests which will improve the health and welfare of generations of dogs.
Full information on the Golden Retrievers PRA DNA test, and information on ordering sample kits, will be available from http://www.aht.org.uk/ from 15 November.
Every UK-based veterinary surgeon that registers as a member of www.vetsurgeon.org by 1st November 2010 will be entered into a draw to win an Apple iPad 32GB Wi-Fi worth £500.
All existing veterinary surgeon members will also be entered into the draw automatically, so there's no need to re-register. Still, you might like to spread the word about the draw amongst colleagues.
Full terms and conditions are available by clicking here.
The Kennel Club has announced it will be launching the Veterinary Practice Guide to Dog Health, a new guide to dog health for veterinary surgeons at the BVA Congress 2010 (Sept 23rd - 25th).
According to the organisation, The Veterinary Practice Guide to Dog Health has been specially developed to provide veterinary surgeons and other practice staff with a handy, updatable resource which covers a range of topics including breed specific information for all 210 recognised pedigree breeds and the range of health testing available to breeders and owners.
The guide contains information on the Kennel Club's Accredited Breeder Scheme, which currently has around 5,300 members who commit to good breeding practice, and the Fit For Function: Fit For Life campaign which aims to ensure that all dogs are able to lead their lives to the full by ensuring that they are fit enough to fulfil the function for which they were originally developed.
The guide provides details about the reporting of operations which alter the natural conformation of a dog, and a sample form which veterinary surgeons can copy and then use to report such operations to the Kennel Club. It also contains a full set of Kennel Club information guides covering a wide range of topics and examples of Kennel Club registration certificates for dogs from both standard registrations and Kennel Club Accredited Breeders to help advise puppy owners what to expect when buying a Kennel Club-registered dog.
Other topics included in the manual are a range of Kennel Club initiatives which veterinary surgeons may find useful to pass on to their clients, such as information on the Good Citizen Dog Training Scheme, the UK's largest dog training programme, and Petlog, the UK's largest microchipping and pet reunification database.
The Kennel Club's Veterinary Advisor, Nick Blayney said: "The Kennel Club Veterinary Practice Guide to Dog Health is intended to assist veterinary surgeons and all practice staff gain information about the two hundred or more breeds of dog recognised by the Kennel Club and any related health issues.
"The Kennel Club is very aware that veterinary surgeons are keen to promote the breeding of healthy puppies, but would find it useful to obtain information about the many health tests and screening schemes available and recommended for each breed. This manual is intended to provide detailed advice on these tests and schemes on a breed by breed basis to assist vets in helping clients to understand the different conditions which may affect individual breeds."
The guide will be made available as an A4 ring binder, with the first fifty available at the BVA Congress. Recipients will be asked to agree to a follow-up visit from one of the Kennel Club's Accredited Breeder Advisors, whose role involves inspecting the breeding premises of the scheme's members to ensure that the standards required by the scheme are kept, and also establishing relationships with veterinary surgeons around the country. There are currently 14 Kennel Club Accredited Breeder Advisors across the UK and they will also be responsible for distributing the remaining copies to veterinary surgeries in the future.
Alongside the launch of the guide, a new dedicated area for veterinary surgeons has been added to the Kennel Club website at www.thekennelclub.org.uk/vets. This will include links to many of the subjects contained in the manual, and will initially feature the top 20 breeds registered in the UK. Future updated content will be added to the website as it becomes available, and the manual will subsequently be produced as a computer disk for wider distribution and convenience.
Veterinary surgeons who are not attending this year's BVA Congress, but wish to obtain a copy of the Veterinary Practice Guide to Dog Health, should visit the new section of the website and complete the request form. A representative of the Kennel Club's Health and Breeder Services team will then make contact to establish a suitable date and time for an Accredited Breeder Advisor to visit.
Royal Canin has launched a new urinary range for cats and dogs. There are four new products including the veterinary market's first canine pouch.
The launch also includes a 20 page booklet for owners which explains the urinary system, different types of problem and stone, and why and how diet can make a difference. Royal Canin says this should be a real boost to encouraging owners to adopt the new diet.
According to the company, the pouch format is highly palatable, convenient and easy for owners to use, which will ultimately lead to improved compliance once a prescription has been made.
Canine Urinary S/O comes in a 150g pouch, and dissolves struvite uroliths as well as diluting the urine to decrease oxalate concentration and ensure the bladder is regularly washed out. Feline Urinary S/O Moderate Calorie in a 100g pouch is for adult cats with difficulty maintaining ideal weight (neutered, overweight, low activity levels) and is indicated for the nutritional management of cats with feline idiopathic cystitis, struvite urolithiasis, and the management of recurrent struvite and calcium oxalate stones.
New dry food additions include Canine Urinary S/O Moderate Calorie with the same benefits in formulation to help limit weight gain, while Canine Urinary S/O Small Dog offers benefits for the smaller canine population; particularly important as 50% of all stones analysed in reference laboratories worldwide come from small breed dogs.
Royal Canin Director of Scientific Communications Pauline Devlin said: "Urinary problems are a common reason for veterinary consultation, and this new range brings together our existing products with four new ones, meaning that vets can be even more precise in prescribing the clinical diet which will best suit the owner and the nutritional management of the pet, meaning that compliance levels will improve."
Royal Canin says neutering and obesity are known predisposing factors for urolithiasis, and some patients are more prone than others - Persian and Burmese cats are predisposed to oxalate stones for example. Age and sex have also been recognized factors influencing the risk of both struvite and oxalate stones. In dogs, small breeds such as the Bichon Frise, Miniature Schnauzer, Poodle, Shih Tzu and Yorkshire Terrier are at risk, while Dalmatians have a tendency to ammonium urate stones.
Royal Canin's urinary diets should be fed for a period of five to twelve weeks, and have been proven to dissolve uroliths in as little as 17 days. To avoid recurrence of clinical signs it is recommended their use is continued as required.
The Royal Canin Urinary range is available from all veterinary wholesalers. Find out more by contacting your Veterinary Business Manager, visiting http://www.royalcanin.co.uk/, or by calling 0845 717 800.
Some say he pees Propofol, and that he once proposed to a Black Welsh Mountain Sheep called Blodwen. All we know is he's called The Stinge, and that he's challenged veterinary surgeons and nurses to beat his lap time in an electronic 'reasonably priced car' at the Alstoe Animal Health stand (G40) at the London Vet Show.
Alstoe says that for legal reasons (and because it doesn't have the money), The Stinge's better known cousin from BBC's Top Gear will not be making an appearance.
However the company is able to run to a bottle of champagne for the vet or nurse that sets the best lap time each day of the show.
Niall McFerran from Alstoe said: "Believe me, the Stinge is not a fast driver, so I think it will be very easy for the first contestant to beat him/her! The real question will be who is actually fastest each day. We are looking forward to having some fun".
Davies Veterinary Specialists (DVS) has confirmed its programme of free CPD for vets over the next 10 months, including a special Orthopaedics Roadshow this autumn.
The evening CPD sessions will be held in the practice's purpose-built lecture theatre and will run monthly from October 2010 until July 2011. Meanwhile the roadshows will run throughout October and November, visiting four venues in London and the Home Counties north of the city.
The CPD meetings are all free of charge. They will cover a broad range of topics including anaesthesia (21st July 2011), cardiology (21st April 2011), cytology/oncology (19th May 2011), diagnostic imaging (24th March 2011), ophthalmology (23rd June 2011), orthopaedics (21st & 28th Oct, 4th & 11th Nov 2010), medicine (20th Jan 2011), neurology (25th Nov 2010) and soft tissue surgery (24th Feb 2011), presented by leading specialists from DVS. They will be held on the evening of the third Thursday of every month, with registration commencing at 7pm.
Complimentary drinks and a finger buffet are included. The evenings will close at 9pm, including time for questions and informal discussion. CPD certificates will be provided on request. For further details please contact Marion Kitchener on 01582 883950 or email marion.kitchener@vetspecialists.co.uk
The Orthopaedics Roadshow will kick off at DVS in Hertfordshire on 21 October. DVS's veterinary orthopaedics experts Richard Whitelock, David Thomson, Rob Rayward, Manuel Jiménez Peláez and Mark Morton will then take to the road to visit Aylesbury, Northampton and North London, to share knowledge on common orthopaedic conditions.
Veterinary nurses are invited to attend DVS's in-house nurses CPD programme, free of charge, by prior arrangement. Seminars are being run monthly from 20 September until 22 November 2010. A programme for 2011 will be available in the near future, for further information contact DVS Training Manager Liz Branscombe on 01582 883950 or email lbranscombe@vetspecialists.co.uk
Dr David Gould, who organises DVS's veterinary CPD, said: "The last CPD series sparked some excellent questions and discussion. With the new programme we have decided to stick to one discipline per session rather than two, to make sure we have plenty of time to accommodate as many questions and view points as possible. The orthopaedics roadshow is a new venture, motivated by a desire to make our experience of the wide variety of interesting orthopaedics cases we have received as accessible as possible to small animal practitioners."
For further details on DVS visit the website at http://www.vetspecialists.co.uk/
The British Veterinary Association and British Cattle Veterinary Association have welcomed the launch of the Defra consultation on tackling bovine Tuberculosis (bTB) in England, which includes recommendations for badger control in areas where bTB persists at high levels, despite attempts at control using other measures.
The two associations have long argued that bTB cannot be controlled without measures to control the disease in both cattle and wildlife.
In particular the BVA and BCVA have welcomed:
The Associations have noted the expectation that the farming industry will pick up the costs of vaccinating and culling badgers and will consider in detail the Government's proposals for licensing criteria and culling methods.
The BVA and BCVA will be providing a detailed response to the consultation following discussion with members of both Associations.
Professor Bill Reilly, President of the BVA, said: "We are extremely pleased that the Coalition Government has made tackling bovine TB such a priority. Both the BVA and BCVA have made the case that this devastating disease will not be eradicated without measures that tackle TB both in cattle and in wildlife.
"We will be looking in detail to ensure that the proposals are as effective and, importantly, as humane as possible.
"Our initial reaction is that the proposals announced by Defra are based on scientific evidence and expert veterinary advice and we strongly support the direction the Government is taking."
Keith Cutler, President of BCVA, added: "It is important that the Government has recognised that there is no single solution to tackling bovine TB.
"Controlling the disease in badgers through vaccination and culling has a role to play, but will only be effective if properly targeted and used alongside all other available control measures.
"The BVA and BCVA are therefore very pleased to see proposals that deliver a package of measures."
CEVA Animal Health has produced Understanding sacroiliac disease, a leaflet to help horse owners understand the cause, diagnosis and management of sacroiliac disease.
CEVA says sacroiliac disease can be a particular challenge because although it can occur in isolation it often occurs in addition to other sources of hindlimb lameness. Acute sacroiliac injury is usually a result of trauma, such as a fall, which may cause pelvic rotation or fracture, resulting in hindlimb lameness and sensitivity to palpation of the tubera sacrale soon after injury. With chronic sacroiliac disease there is usually no history of trauma, rather a prolonged history of poor performance.
Understanding sacroiliac disease explains the anatomy of the sacroiliac joint, the clinical signs of the disease, how it is diagnosed, the treatment options and the general prognosis. The leaflet is available to equine vet practices as a useful information source for clients. You can order free copies from your CEVA sales representative.
Pfizer Animal Health has launched Vet Support+ a dedicated veterinary business consultancy team with a brief to boost the profitability and productivity of veterinary practices across the UK.
Staffed by a team of seven business consultants who have undertaken academic and practical training to add to their experience in the veterinary industry, Vet Support+ will offer tailored support to practices in a format which aims to offer flexibility and a rapid return on investment. The services range across the three critical areas of business operations, client relations and staff management. Consultants will initially focus on supporting practices operating in the companion animal sector, extending their service to the dairy sector early in 2011.
According to Pfizer, the Vet Support+ service has been developed in response to detailed research among practices to understand their requirements for business advice and support. It's launched against a backdrop of continued stagnation in the veterinary sector according to latest data from the Fort Dodge Index benchmark of practice performance. Vet Support+ will operate independently of the pharmaceutical business with no sharing of information or data.
Vet Support+'s consultants are based across the UK in order to be convenient for practices in any part of the country.
The team is headed by Laura Jenkins, who has held a range of senior roles at Pfizer UK. Laura said: "Many vets working in practice relish the clinical side of their work for which they have trained so hard. It can therefore come as a shock to many that they also find themselves responsible for running the business side of the practice for which they may have received virtually no guidance during their training. They have a real need for objective, practical advice they can trust, which is based on a detailed knowledge of the market. Many also appreciate 'hand-holding' and coaching through the tough process of making changes required within the practice in order to put it on a more stable and successful footing. The continuing challenges of the economic climate make it imperative that practices take bold steps now to ensure not only that they're able to withstand the continued recession but are well-positioned to take advantage of the upturn when it comes.
"Our Vet Support+ consultants are highly experienced in the veterinary market and have received very positive feedback from the practices they've worked with during a pilot of the service. They're focused on demonstrating significant value to their clients and achieving early results on the bottom line. They'll be looking to build a close relationship with their client practices, acting as a coach and 'critical friend' as they help them plan for a successful and profitable future."
For further information on the Vet Support+ service please contact Laura Jenkins on 01737 330705.
Genitrix is offering practices a specially designed dosing wheel to ensure the accurate administration of Libromide (potassium bromide), the company's treatment for refractory canine epilepsy.
The wheel indicates the dosage required according to the bodyweight of the dog and also provides further information regarding managing epilepsy and bromide serum testing.
Rob Watkins, Marketing Director at Genitrix, said: "We've consulted canine neurology experts in the design of our dosing wheel and hope it will give practices reassurance and clarity on how to initiate, maintain and review the control of canine epilepsy with Libromide. Following the launch of Libromide and the discounted blood test service, the dosing wheel is an additional initiative to help improve treatment approaches for canine epilepsy."
To receive a free dosing wheel or for more information on Libromide and the discounted blood test service, practices are asked to call Genitrix' head office on 01403 786345 or contact their account manager.
Pfizer VPS has launched a 'Pre-Sale Scab Treatment Certificate' so that sheep treated for sheep scab and protected against re-infestation beyond their autumn sale date can be formally certified as such.
A choice of two moxidectin-based treatments are eligible for use, one with 28 days and the other 60 days licensed persistency against the scab mite.
Pfizer VPS vet David Bartram explained that following treatment, the sale date must fall within the persistency window: "The idea is that farmers present their certificate at markets on sale day, then auctioneers announce the scab-protected status during their sales patter. Whether this adds to the sale price will be interesting to find out, but it's sure to be seen as a valuable attribute by buyers who won't need to treat for scab when they arrive home."
Details of the certification process are available from SQPs at animal medicine suppliers. The two eligible treatments are CYDECTIN 1% LA and CYDECTIN 2% LA for sheep.